Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines

Go back to Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines

CVS Health Research Institute Encourages Reconsideration of Current Cholesterol Management Guidelines as New Class of High-cost Drugs Hit the Market

August 10, 2015 11:05 AM EDT

WOONSOCKET, R.I., Aug. 10, 2015 /PRNewswire/ -- In a commentary published online first today in the Journal of the American Medical Association (JAMA), CVS Health (NYSE: CVS) Research Institute experts encouraged the cardiology community to review and reconsider current treatment guidelines for the management of high cholesterol. As a new class of high-cost cholesterol lowering drugs, known as PCSK9 inhibitors, comes to market, current American College of Cardiology/American Heart Association (ACC/AHA) guidelines, could complicate treatment choices and inhibit utilization management tools to manage... More

Boston Medical Center Teams Up with Rhode Island Hospital, CVS Health to Address Use of Pharmacy-Based Naloxone to Combat Opioid Addiction and Overdoses

August 6, 2015 10:30 AM EDT

BOSTON, Aug. 6, 2015 /PRNewswire/ -- Boston Medical Center (BMC) has received a $1.3 million grant from the Agency for Healthcare Research and Quality (AHRQ) to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose death in two New England States: Massachusetts and Rhode Island. The study will be conducted in partnership with Rhode Island... More